Uncategorized

The Russian Sex-ploration By Joshua Colls, Biology, 2017 Following suit with Russia’s stereotypically obscure yet innovative ideas, came the Sex Geckos. A mid-summer copulation experiment set off on July 19th to analyze the effects of zero gravity on sexual habits and performance of 1 male and 4 female geckos, as well as Drosophila fruit flies, […]

Big Whales in the Big Apple By Andrew Bloy, Biology, 2017 In New York City, tourists flock from every corner of the globe to see the majestic skyscrapers, storied avenues, and iconic landmarks like the Statue of Liberty. However, less than five miles from Lady Liberty’s feet, there are new sights to see for visitors to

Ebola: A Solution on the Horizon By Olaide Adekanbi, Behavioral Neuroscience, 2017 In recent history there have been major disease outbreaks that have caused worldwide panic and fear. There was the Mad Cow Disease scare in the late 90’s and the more recent Swine flu in 2009. Now another disease outbreak has commanded the attention of

Meeting Healthcare in South Africa: First Impressions By Julie Hugunin, Biology, 2017 Just as we begin to poke the woman with a needle the power goes out — again. “Are you sure we shouldn’t be worried?” my unsteady voice asks, clearly naïve and inexperienced to life in a South African township. “Yes, electricity is always a problem

The Lion Queen: Burn Baby Burn Sumayah’s Co-op at an African Wildlife Preserve: 1st Installation By Sumayah Rahman, Biology, 2015 On September 22nd, after a long journey with three flights, I landed in Hoedspruit, the “wildlife capital” of South Africa! This semester, I am doing a co-op at the Askari Wilderness Conservation Program, located on the

Regulation and Science: Biosimilars Waiting to Debut in the US Editorial by Josh Sternberg, Editor-in-Chief at Northeastern Univeristy Political Review The pharmaceutical industry is experiencing tectonic shifts, with widespread effects on the traditional business models of pharmaceutical companies. Drying pipelines, pricing pressures, health care reform, and rising costs of research and development are forcing pharmaceutical companies

Profiles in Innovation: Dr. Ross Cagan If you were to pass Dr. Ross Cagan on the street, you would peg him as a sophisticated lead guitarist in an underground band before you pegged him as one of the world’s foremost cancer researchers. Maybe that has something to do with his past life as a rockstar in

The US Cares 22.3% Less About Cancer If you’re reading this, and you’re male, your chance of developing cancer during your lifetime is 44%. If you’re female your odds are slightly better at a whopping 38%. For people planning to die of something other than a cancer, like a Viagra-induced heart attack in a retirement home,

Should GMOs be labeled? By Gwen Schanker Whether organisms should be genetically modified has been a subject of debate since the 1970s, when scientists Stanley Cohen and Herbert Boyer created the first recombinant DNA organism and transgenic plants emerged as the newest breakthrough in biotechnology. Genetic modification of crops allows for greater yields at a lower